These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Arvin AM Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912 [TBL] [Abstract][Full Text] [Related]
29. [Item 84--Herpesvirus infections in the child and the immunocompetent adult: chickenpox and shingles]. CEDEF Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A22-8. PubMed ID: 23176852 [No Abstract] [Full Text] [Related]
30. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. Levin MJ; DeBiasi RL; Bostik V; Schmid DS J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373 [TBL] [Abstract][Full Text] [Related]
31. Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant. Chan Y; Smith D; Sadlon T; Scott JX; Goldwater PN J Paediatr Child Health; 2007 Oct; 43(10):713-5. PubMed ID: 17854459 [TBL] [Abstract][Full Text] [Related]
32. Herpes zoster after varicella vaccination in a healthy young child. Obieta MP; Jacinto SS Int J Dermatol; 2008 Jun; 47(6):640-1. PubMed ID: 18477170 [No Abstract] [Full Text] [Related]
34. The effectiveness of varicella vaccination during an outbreak in a children's day-care center. Kiliç A; Unüvar E; Yilmaz C; Yildiz I; Oğuz F; Sidal M Vaccine; 2008 Jun; 26(27-28):3371-2. PubMed ID: 18490083 [No Abstract] [Full Text] [Related]
36. Varicella zoster virus: review of its management. Mustafa MB; Arduino PG; Porter SR J Oral Pathol Med; 2009 Oct; 38(9):673-88. PubMed ID: 19691461 [TBL] [Abstract][Full Text] [Related]
37. Impact of varicella vaccine on varicella-zoster virus dynamics. Schmid DS; Jumaan AO Clin Microbiol Rev; 2010 Jan; 23(1):202-17. PubMed ID: 20065330 [TBL] [Abstract][Full Text] [Related]
38. Varicella immunization and herpes zoster. Volpi A Herpes; 2005 Dec; 12(3):59. PubMed ID: 16393520 [No Abstract] [Full Text] [Related]
39. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals. Chris Maple PA; Gunn A; Sellwood J; Brown DW; Gray JJ J Virol Methods; 2009 Feb; 155(2):143-9. PubMed ID: 18996415 [TBL] [Abstract][Full Text] [Related]
40. Prevention strategies: experience of varicella vaccination programmes. Patrick D Herpes; 2007 Sep; 14 Suppl 2():48-51. PubMed ID: 17939897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]